Pharmafocus and Pharmafile

Pharmafocus and Pharmafile
Share

Pharmafocus and Pharmafile

 •  September 12

Shortly after the news that Teva had , it also announced that it had managed to sell its contraceptive brand Paragard for $1.1 billion. The deal represents a positive step for the company in raising the $2 billion it needs to pay down its debts for the financial year. Paragard is part of Teva’s Women’s Health unit; the product is an intrauterine...

Novartis has received approval for its CAR-T treatment of paediatric and young adults with a form of acute lymphoblastic leukaemia (ALL). The approval marks a breakthrough for this type of treatment that reengineers the body’s own immune system to combat cancer and had the FDA referencing its decision as ‘historic’. It was an approval that was...

While undisclosed, the sum is thought to be equivalent to tens of millions of pounds. The £150 million facility is used to produce the company’s breast cancer drugs, including Zoladex, which has seen its R&D efforts transferred to AZ’s laboratories at its Alderley Park site in Cambridge. The Chesire facility currently employs 300 staff and is part...

Thus far, Samsung Bioepis has made its name by being a thorn in the side of the producers of original drugs. It has become a world leader in producing biosimilars, already gaining approval for a biosimilar to J&J’s Remicade whilst having decisions pending on several others. Now, it has formed a partnership with Takeda to begin the search for its...

The FDA has announced that it has been forced to recall a range of liquid pharmaceutical and dietary supplement products due a possible bacterial contamination which could pose a threat to vulnerable patients through threat of serious infection. The range of products, manufactured by US firm PharmaTech, include vitamin D drops, multivitamins, and...

The campus will initially focus on the manufacture of AmBisome, an antifungal medication that is used to combat fungal infections and a form of meningitis in people carrying HIV. As well as this, the campus will have the capacity to package, label and distribute other treatments owned by the company, including its hepatitis C treatments. “Up to 14...

Endo International has announced that it will close down its manufacturing and distribution facilities in Huntsville, Alabama, as part of a larger restructuring of its manufacturing network. The decision will see the company scale back its operations in the area gradually over the next 12 to 18 months, which will see 875 jobs lost as a result of...

The Central Drugs Standard Control Organisation (CDSCO) tested drugs to determine whether they were of standard quality but found that 946 of the medicines across 66 companies failed the test. One of the companies responsible for a surprising number of these was Pfizer, having 25 medicines that were not of quality. The survey is part of an overall...

In a press conference at the White House, President Trump, alongside representatives from Corning, MSD and Pfizer, announced that 1,000 jobs would be created in a new pharmaceutical glass packaging initiative. It comes as part of Trump’s ‘Made in America Week’, to highlight manufacturing that is done within the US and potentially to deflect...

McKinsey & Company discuss how pharma company executives need to seize every opportunity to embed productivity in their thinking and incorporate it into every change effort they undertake. As leaders consider their company’s path forward, any improvement program, whether limited and local or broad and far-reaching, should have productivity at its...